SAN DIEGO, Oct. 7, 2015 /PRNewswire/ -- ResMed
(NYSE:RMD) today announced it has completed the previously
announced acquisition of Curative Medical, a leading provider of
non-invasive ventilation and sleep-disordered breathing medical
devices and accessories.
"By joining forces with Curative Medical we expand our combined
reach in the growing respiratory medical device market in
China," said Mick Farrell, CEO of ResMed. "Together we will
focus on improving patient quality of life while reducing the cost
of care for sleep-disordered breathing and chronic obstructive
pulmonary disease."
ResMed China and Curative Medical will remain operationally
independent, and Curative will continue to invest in R&D,
manufacturing, marketing and sales teams in China. Curative will keep its name, brands,
and innovative offerings tailored for the Chinese market and other
global markets, and will be strategically positioned to target
different customer segments than ResMed. Curative employees,
including the founder and chief executive officer, Jason Sun, will continue as employees of the
combined ResMed and Curative team.
Financial terms of the transaction were not disclosed.
Ongoing Support
Curative Medical will continue to
support its products through its existing sales team and
distribution network.
About Curative
Founded in 2008, Curative has its
manufacturing base in Suzhou, China, offices in Beijing, Germany and the
United States, and a distributor network throughout
China and in other select markets.
Curative Medical is a leading innovator, designer, and manufacturer
of medical devices for sleep-disordered breathing and chronic
obstructive pulmonary disease, and has leveraged its expertise in
China to drive its growth in other
global markets. For more information about Curative, visit
www.curativemedical.com.
About ResMed
The global team at ResMed (NYSE:RMD) is
united in the commitment to change millions of lives with every
breath. With more than 4,000 employees and a presence in over
100 countries, the company has been pioneering new and innovative
devices and treatments for sleep-disordered breathing, chronic
obstructive pulmonary disease, and other chronic diseases for more
than 25 years. ResMed's world-leading products and innovative
solutions improve the quality of life for millions of patients
worldwide, reduce the impact of chronic disease, and save
healthcare costs. For more information about ResMed and its
businesses, visit www.resmed.com or follow @resmed on Twitter.
ResMed
Contacts:
|
|
For News
Media
|
For
Investors
|
Alison
Graves
|
Agnes Lee
|
Global Corporate
Communications
|
Senior Director,
Investor Relations
|
O:
858-836-6789
|
O:
858-836-5971
|
news@resmed.com
|
investorrelations@resmed.com
|
Logo -
http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/resmed-completes-acquisition-of-curative-medical-a-leader-in-sleep-disordered-breathing-and-respiratory-care-medical-devices-300156152.html
SOURCE ResMed Inc.